BDBM50393342 CHEMBL2152252

SMILES CNC(=O)c1nc(cnc1N)-c1ccc(Cl)c(c1)S(=O)(=O)Nc1cccc(F)c1F

InChI Key InChIKey=GEYLKEHPEKRUTC-UHFFFAOYSA-N

Data  30 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 30 hits for monomerid = 50393342   

TargetFibroblast growth factor receptor 1(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of FGFR1More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 18nMAssay Description:Inhibition of PI3KdeltaMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of CDK1/CyclinBMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human CYP3A4 using midazolam as substrate after 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase Chk1(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of CHK1More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetAurora kinase B(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of Aurora kinase BMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 773nMAssay Description:Inhibition of human PI3Kgamma expressed in C5a-stimulated mouse RAW 264.7 cells assessed as inhibition of AKT phosphorylation by ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSerine/threonine-protein kinase mTOR(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 623nMAssay Description:Inhibition of mTORMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of SRCMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of PDK1More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of Platelet-derived growth factor subunit BMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetInsulin receptor(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of IRKMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of Flt3More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 18nMAssay Description:Inhibition of human PI3Kgamma expressed in sf9 cells assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 739nMAssay Description:Inhibition of EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 206nMAssay Description:Inhibition of CRAF1More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of CDC7More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetHepatocyte growth factor receptor(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of c-MetMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetRAC-alpha serine/threonine-protein kinase(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of AKT1More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human CYP3A4 using testosterone as substrate after 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 591nMAssay Description:Inhibition of human CYP2C9 using tolbutamide as substrate after 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C8(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 2.33E+3nMAssay Description:Inhibition of human CYP2C8 using paclitaxel as substrate after 45 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human CYP2C19 using mephenytoin as substrate after 45 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Exelixis

Curated by ChEMBL
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human CYP1A2 using phenacetin as substrate after 15 mins by LC/MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 1.73E+4nMAssay Description:Inhibition of human Erg expressed in CHO cells after 5 minsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 690nMAssay Description:Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescen...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 2.06E+3nMAssay Description:Inhibition of human PI3Kbeta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescenc...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50393342(CHEMBL2152252)
Affinity DataIC50: 435nMAssay Description:Inhibition of human PI3Kalpha expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescen...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed